Novonix (NVNXF) Payables (2020 - 2025)

Novonix has reported Payables for 6 years, with the latest figure at $75.4 million in Q4 2025.

• For the quarter ending Q4 2025, Payables rose 87.57% year-over-year to $75.4 million; the trailing twelve-month figure through Dec 2025 stood at $75.4 million (up 87.57% YoY), and the FY2023 full-year result was $6.6 million, down 4.72% from the prior year.
• Payables for Q4 2025 stood at $75.4 million, up from $19.5 million in the prior quarter.
• The five-year high for Payables was $75.4 million in Q4 2025, with the low at $2.4 million in Q4 2021.
• Historically, Payables has averaged $20.1 million across 5 years, with a median of $6.8 million in 2022.
• Annual changes were most pronounced in 2024 — Payables jumped 769.52% — and 2025, when it plunged 48.78%.
• Novonix's Payables stood at $2.4 million in 2021, then soared by 194.27% to $7.0 million in 2022, then retreated by 4.72% to $6.6 million in 2023, then surged by 506.56% to $40.2 million in 2024, then soared by 87.57% to $75.4 million in 2025.
• The last three Payables figures came in at $75.4 million (Q4 2025), $19.5 million (Q2 2025), and $40.2 million (Q4 2024), per Business Quant data.